Well said.

The age old question is "Would you buy the stock now?":
140 million in cash, no debt, EMA encouraging our advances, FDA accelerated approval application coming in a known and timely manner, phase 2 trial in a second drug started, at the minimum an adult Rett approval likely, increasing institutional ownership...
Yes I would buy and did on Friday.
Things have never looked brighter.

Could use some clarification on something.
It was mentioned in the past that once you complete a phase 2 trial on a particular drug you can go directly to phase 3 for other indications using the same drug.
Would this mean we could go directly to a phase 3 for FTD later this year?

TD Ameritrade show 6.5 million shares traded on Friday.

Researchers make precious headway into a genetic form of Alzheimer's disease.

https://medicalxpress.com/news/2024-02-precious-headway-genetic-alzheimer-disease.html

Fools use the term "house money", ask any casino owner.

Interesting CMS/FDA article
https://www.statnews.com/2024/02/02/medicare-cms-fda-approval-drugs-safety-older-americans/

Anyone care to weigh in?
https://news.yahoo.com/nose-picking-likely-partially-blame-205347245.html

Tom Bishop is very upbeat about Anavex, as he should be.
One interesting fact he brought up is the U.S .schizophrenia population is 250 times larger than the Rett population.

" I will sadly reduce my position here"
You seem ill-suited for investing in individual companies.
Might I recommend index funds?

My wife took her friend who's in the early stages of dementia to her neurologist yesterday.
She asked the doctor if she had heard of Anavex and their AD drug.
The doctor said yes she had and then went into a wild eyed tirade about how horrible the MAB drugs were with their massive brain bleeds and the like.
Just one neurologists opinion from southeastern Wisconsin.

I would think because rather than a patient (reluctantly for some) telling his doctor about their forgetfulness it will be the doctor telling the patient their test results suggest a daily blarcamesine pill would be in order.

My mom never went to the doctor as she sunk deep into dementia and the staff at the memory care center said sometimes the patients would even fool them.
Who knows how early that particular talent manifests itself.

Me too, but I still think it's a fine idea.
I own some Jan/25's and Jan/ 26's.
I'm willing to lose a fair amount of money in the short term as I strongly believe Anavex will have commercial sales eventually.

I think it's closer to resistance than to support but then I have a dim view of TA in general.

Well I'm happy.
I didn't like having no trials running.
Very hopeful for Rett and AD but having irons in the fire is sage wisdom.

Another good reason to file for approval anywhere and everywhere.

https://www.bbc.com/news/uk-england-67924234

I always thought Rett was the ace in the hole.
If we struggled with AD, PDD... the revenues from Rett would make Anavex a going concern with minimal dilution going forward.

Now that' has flipped for me.
I was greatly heartened by the EMA news and hope for additional filings.

Nonetheless, I've lightened up on my shares(was/still am overweight) due to Dr. Missling's lack of transparency.

Saying there would be no more trials in the immediate future because the results from the latest AD trial were so compelling that it would be in the best interests of the company to solely focus on AD would be a positive for the share price in my opinion.

To quote Spock, "The needs of the many outweigh the needs of the few."
AD are the many.

#4 in particular annoys me.
It's as if he's telling a child if you brush your teeth and make your bed there may be a surprise for you.

And we might as well forget the Fragile X trial.
If your blindsided by the known high placebo response in juveniles in a simpler Rett trial how can they manage a trial that they said would have multiple tranches?

Big short exiting taking place?

I'm still long but ever so weary of guessing.

A year ago I thought we'd currently be running a Fragile-x trial, waiting on news of our NDA or beginning another trial for PDD, acting on the results from the imaging study, dreaming of what might follow the schizophrenia trial...
How much fun we'd be having talking about all that.

Instead I'm in the dark eating cow poop.

Since my parents have passed if I knew their names I could mention to them my current status is "adoptable".

Good to see.
It's taken forever for the world to acknowledge we even exist but that's been changing as of late.

And they've never been profitable?

And it drives me nuts that people are having discussions which might make me rich and I'm totally unaware of any of the details.

I'll be here until the cows come home.

LOL

Was it the same CEO and/or BOD for those 25 years?

I can't help but to be amused that we beat SAVA like a red headed stepchild for their antics but if we do similar things it's for the greater good.

This post is not directed at anyone in particular.

Aye!

Not happening.
But we're numb to it at this point.

I find value in their other postings but investor2014 owns them for some reason.
I get the argument that for the sake of those new to the Anavex ihub board his postings must be refuted but I think it's really used as an excuse to engage.

I'm kinda bummed that I put investor2014 on ignore but so many of you are responding to him I feel I've failed somehow.

I think they gave the thumbs up in just a month to make that confusing pile of paperwork go away.

Maybe Anavex announces TGA conditional approval next week and these videos are to inform and set expectations?

That's what I was thinking on my walk today.

You sound more like a petulant child than a doctor to this layman.

Glad to see this is still a thing in the about Anavex part.

" pain, and various types of cancer."

"the fact everyone there is covered means more people will have access"

BRILLIANT!

Since it fixes a myriad of problems it would behoove them to give it anyone and everyone.

Well said.

Where do you think SAVA would be if they announced they'd begun the paperwork for AZ with the EMA?

I was going to change that to partial data but I like bas2020's slant better.

Do you think they saw the 2/3 of the OLE patients data that's 96 wks+?